Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Justin Keywood is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/09/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/23/2023 | MDP | Buy Now | Medexus Pharma | — | — | Justin Keywood | → $1.8 | Upgrade | Hold → Speculative Buy | Get Alert |
| 06/01/2023 | CPHRF | Buy Now | Cipher Pharmaceuticals | — | — | Justin Keywood | $0.95 → $4.75 | Upgrade | Hold → Speculative Buy | Get Alert |
| 03/23/2023 | AND | Buy Now | Andlauer Healthcare Group | — | — | Justin Keywood | → $62 | Reinstates | → Buy | Get Alert |
| 01/11/2023 | ATS | Buy Now | ATS | $21.00 | 257.14% | Justin Keywood | $66 → $75 | Maintains | Buy | Get Alert |
